Noninvasive respiratory supports in ICU.

Area of Science:

• Critical Care Medicine
• Respiratory Medicine

Background:

• Noninvasive respiratory support is crucial for critically ill patients with acute respiratory failure.
• It helps avoid invasive ventilation, reduces complications, and aids in weaning.
• It's also used for preoxygenation during intubation to improve safety.

Purpose of the Study:

• To compare the efficacy of high-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) in various respiratory failure scenarios.
• To evaluate their roles in preoxygenation, acute hypoxemic respiratory failure, COPD exacerbations, and post-extubation support.

Main Methods:

• HFNO decreases dead space, provides stable oxygen, and generates positive airway pressure.
• Positive-pressure noninvasive supports like CPAP and NIV improve oxygenation.
• NIV, unlike CPAP, reduces inspiratory effort and increases tidal volume.

Main Results:

• HFNO is the first-line therapy for acute hypoxemic respiratory failure.
• NIV is the reference treatment for COPD exacerbations with respiratory acidosis.
• NIV is optimal for preoxygenation during intubation; HFNO is an alternative for non-hypoxemic patients.

Conclusions:

• HFNO is the preferred initial treatment for acute hypoxemic respiratory failure.
• NIV remains the gold standard for COPD exacerbations and intubation preoxygenation.
• Both NIV and HFNO improve outcomes post-extubation compared to conventional oxygen therapy.